Primary breast angiosarcoma – a case report

dc.contributor.authorOstańska, Elżbieta
dc.contributor.authorAebisher, David
dc.contributor.authorKaznowska, Ewa
dc.contributor.authorBartusik-Aebisher, Dorota
dc.date.accessioned2021-03-11T12:01:55Z
dc.date.available2021-03-11T12:01:55Z
dc.date.issued2020
dc.description.abstractIntroduction. Angiosarcoma is a rare breast cancer that can be primary or secondary after surgery or after breast cancer radiotherapy. It is important that breast angiosarcoma belongs to tumors with a non-specific clinical and radiological picture. Aim. The study of the biopsies contained aggressive vasomotor hyperplasia. Description of the case. The presented case concerns the primary angiosarcoma of the right breast in a 56-year-old woman who had never had a surgical procedure before, nor radiotherapy in the area of the breast. Conclusion. Histopathological examination supported by immunohistochemistry is a reliable and indispensable diagnostic element in the diagnosis of vascular sarcoma.pl_PL.UTF-8
dc.identifier.citationEuropean Journal of Clinical and Experimental Medicine T. 18, z. 4 (2020), s. 331–334pl_PL.UTF-8
dc.identifier.doi10.15584/ejcem.2020.4.12
dc.identifier.eissn2544-1361
dc.identifier.issn2544-2406
dc.identifier.urihttp://repozytorium.ur.edu.pl/handle/item/6112
dc.language.isoengpl_PL.UTF-8
dc.publisherWydawnictwo Uniwersytetu Rzeszowskiegopl_PL.UTF-8
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectbreast biopsypl_PL.UTF-8
dc.subjecthistopathological examinationpl_PL.UTF-8
dc.subjectimmunohistochemistrypl_PL.UTF-8
dc.titlePrimary breast angiosarcoma – a case reportpl_PL.UTF-8
dc.typearticlepl_PL.UTF-8

Pliki

Oryginalny pakiet

Aktualnie wyświetlane 1 - 1 z 1
Ładowanie...
Obrazek miniatury
Nazwa:
12 ostańska-primary breast.pdf
Rozmiar:
1.53 MB
Format:
Adobe Portable Document Format
Opis:

Pakiet licencji

Aktualnie wyświetlane 1 - 1 z 1
Nazwa:
license.txt
Rozmiar:
1.22 KB
Format:
Item-specific license agreed upon to submission
Opis: